| Application no. and date | 21170716.1 (espacenet) (Federated) (European Patent Register), 20170530 | | Patent/reg. no. and date | DK/EP 3916392, 20240501 | | Publication date | 20211201 | | Priority no. and date | EP 16171885, 20160530 | | EP pub. no. and date |
EP 3916392 20211201 | | Effective date | | | Applicant/owner | Incyte Corporation, 1801 Augustine Cut-Off
Wilmington, DE 19803, US | | Applicant ref. no. | V474924DK00 | | Inventor | BOXHAMMER, Rainer,
83059 Kolbermoor, DE,
ENDELL, Jan,
80333 München, DE,
WINDERLICH, Mark,
81373 München, DE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | G01N 33/574 (2006.01) | | Title | Fremgangsmåder til at forudsige terapeutiske fordele af anti-CD19-behandlingen hos patienter | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
